Jan 25·edited Jan 25

Hi Decoding Bio Team,

Truly enjoy your BioBytes each week!

I think there might be a typo in today's article. Sanofi acquired one of the assets of Inhibrx but in your article it mentions J&J acquired Inhibrx followed by correct mention of Sanofi buying 8% stake in spun out company.

Let me know if I made wrong assumptions


Expand full comment